申请人:Purdue Pharmaceutical Products L.P.
公开号:US20140066419A1
公开(公告)日:2014-03-06
The present invention is directed to a method of alleviating, relieving, altering, remedying, ameliorating, improving or affecting a neoplastic disease or an immune disease, the method comprising administering to a subject in need thereof an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof:
wherein P, Z, and m are defined herein above.